Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Inv. presentation
Acq. announced
Consulting agrmnt

Enliven Therapeutics, Inc. (IMRA) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Lyssikatos Joseph P (Chief Scientific Officer) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Sold 12,000 shares @ $13.6248, valued at $163.5k
Exercised 12,000 options to buy @ $1.12, valued at $13.4k
09/28/2023 4 5AM Partners VI, LLC (10% Owner) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Sold 164,789 shares @ $15, valued at $2.5M
Sold 32,711 shares @ $15, valued at $490.7k
09/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2023 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Exercised 2,125 options to buy @ $4.28, valued at $9.1k
05/19/2023 4 Gupta Rishi (10% Owner) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Exercised 2,125 options to buy @ $4.28, valued at $9.1k
02/27/2023 4 Schwab Andrew J. (Director) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Granted 4,838,092 shares @ $0
Granted 960,383 shares @ $0
02/27/2023 4 Heyman Richard A. (Director) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Granted 149,820 shares @ $0
Granted 37,407 shares @ $0
Granted 31,172 shares @ $0
Granted 20,657 options to buy @ $2.48, valued at $51.2k
02/27/2023 4 Gupta Rishi (10% Owner) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Granted 7,611,458 shares @ $0
Granted 288,114 shares @ $0
02/27/2023 4 Bauer Jake (Director) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Granted 87,372 shares @ $0
Granted 17,706 options @ $2.48, valued at $43.9k
02/27/2023 4 Derynck Mika K (Director) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Granted 87,373 options to buy @ $2.48, valued at $216.7k
02/27/2023 4 Patel Anish (COO) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Granted 36,722 shares @ $0
Granted 394,027 shares @ $0
Granted 10,767 options to buy @ $1.12, valued at $12.1k
Granted 2,827 options to buy @ $2.48, valued at $7k
Granted 75,620 options to buy @ $2.48, valued at $187.5k
02/27/2023 4 Lyssikatos Joseph P (Chief Scientific Officer) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Granted 1,117,035 shares @ $0
Granted 344,550 options to buy @ $1.12, valued at $385.9k
Granted 88,531 options to buy @ $2.48, valued at $219.6k
02/27/2023 4 Hohl Benjamin (CFO) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Granted 262,120 options to buy @ $2.48, valued at $650.1k
02/27/2023 4 Kintz Samuel (President and CEO) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Granted 1,087,525 shares @ $0
Granted 88,531 shares @ $0
Granted 88,531 shares @ $0
Granted 344,550 options to buy @ $1.12, valued at $385.9k
Granted 404,363 options to buy @ $2.48, valued at $1M
02/27/2023 4 Collins Helen Louise (Chief Medical Officer) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Granted 287,084 options to buy @ $2.48, valued at $712k
02/27/2023 4 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Granted 7,611,458 shares @ $0
Granted 288,114 shares @ $0
02/27/2023 4 COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Bought 622 shares @ $22.072, valued at $13.7k
Acquired 729,891 shares @ $0
02/27/2023 4 RA CAPITAL MANAGEMENT, L.P. (Former 10% owner) has filed a Form 4 on Enliven Therapeutics, Inc.
Txns: Granted 1,152,460 shares @ $0
02/23/2023 4 COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on IMARA Inc.
Txns: Bought 8,194 shares @ $5.249, valued at $43k
Bought 23,565 shares @ $5.113, valued at $120.5k
02/22/2023 4 GRAY MICHAEL (CFO & COO) has filed a Form 4 on IMARA Inc.
Txns: Sold 9,856 shares @ $4.67, valued at $46k
02/22/2023 4 Ballal Rahul D. (CEO) has filed a Form 4 on IMARA Inc.
Txns: Sold 32,861 shares @ $4.66, valued at $153.1k
02/01/2023 4 GRAY MICHAEL (CFO & COO) has filed a Form 4 on IMARA Inc.
Txns: Sold 3,596 shares @ $3.92, valued at $14.1k
02/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy